Galderma Group AG (SWX:GALD)

Switzerland flag Switzerland · Delayed Price · Currency is CHF
147.70
+0.20 (0.14%)
Oct 31, 2025, 1:45 PM CET
0.14%
Market Cap35.02B
Revenue (ttm)3.73B
Net Income (ttm)300.62M
Shares Out237.41M
EPS (ttm)1.26
PE Ratio116.68
Forward PE44.92
Dividend0.15 (0.10%)
Ex-Dividend Daten/a
Volume88,479
Average Volume1,512,154
Open149.10
Previous Close147.50
Day's Range147.40 - 149.40
52-Week Range72.70 - 150.20
Betan/a
RSI63.36
Earnings DateOct 31, 2025

About Galderma Group AG

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes ACTINICA, Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, Mirvaso, NEMLUVIO, Relfydess, Benzac, Loceryl, and TRI-LUMA in therapeutic dermatology. ... [Read more]

Sector Healthcare
Founded 1981
Employees 6,545
Stock Exchange SIX Swiss Exchange
Ticker Symbol GALD
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

Galderma Group AG (GALDY) Q3 2025 Sales Call Transcript

Galderma Group AG (OTCPK:GALDY) Q3 2025 Sales Call October 23, 2025 9:30 AM EDTCompany ParticipantsEmil Ivanov - Head of Strategy, Investor Relations &...

7 days ago - Seeking Alpha

Galderma Group AG (GALDY) Q3 2025 Sales/ Trading Statement Call - Slideshow

2025-10-23. The following slide deck was published by Galderma Group AG in conjunction with this event.

7 days ago - Seeking Alpha

Galderma Announces Departure of Its Chief Financial Officer

Ad hoc announcement pursuant to Art. 53 LR ZUG, Switzerland — Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that Thomas Dittrich, Chief Financial Officer, wi...

4 months ago - Financial Post

Galderma Intends to Buy Back approximately 2.4 Million Shares in the Context of the Accelerated Bookbuild Offering by EQT, ADIA and Auba

ZUG, Switzerland — Galderma Group AG (SWX:GALD): Ad hoc announcement pursuant to Art. 53 LR Galderma intends to repurchase approximately 2.4 million shares in the context of the accelerated bookbuild ...

5 months ago - Financial Post